Literature DB >> 2605389

The multidimensional nature of schizotypal traits: a factor analytic study with normal subjects.

R P Bentall1, G S Claridge, P D Slade.   

Abstract

Fourteen published scales of psychotic traits or symptoms (measuring various delusional states, magical ideation, perceptual aberration, disposition towards hallucination, hypomanic personality, schizotypal personality, borderline personality and anhedonia) were combined with the Eysenck Personality Questionnaire to form a Combined Schizotypal Traits Questionnaire (CSTQ) which was administered to 180 normal subjects. Two factor analyses were carried out on the scale scores. The first analysis excluded symptom scores derived from the Delusions Symptoms States Inventory of Foulds and Bedford and yielded a three-factor solution which appeared to measure traits relating to (i) positive psychotic symptomatology; (ii) negative psychotic symptomatology; and (iii) aspects of schizotypy involving social anxiety and cognitive disorganization. The Foulds scales were included in the second analysis which yielded a four-factor solution. The first three factors were similar to those obtained from the first analysis; the fourth factor seemed to measure an asocial component of schizotypy. This last factor was mainly accounted for by the P scale from the EPQ. These results support previous findings suggesting that different schizotypy scales relate to different underlying aspects of schizophrenia. The findings also indicate that psychotic traits are distributed along at least three dimensions.

Entities:  

Mesh:

Year:  1989        PMID: 2605389     DOI: 10.1111/j.2044-8260.1989.tb00840.x

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  21 in total

1.  Schizotypy, alexithymia, and socioemotional outcomes.

Authors:  James P Seghers; Amanda McCleery; Nancy M Docherty
Journal:  J Nerv Ment Dis       Date:  2011-02       Impact factor: 2.254

2.  Relating schizotypy and personality to the phenomenology of creativity.

Authors:  B Nelson; D Rawlings
Journal:  Schizophr Bull       Date:  2008-08-04       Impact factor: 9.306

3.  Integration and development in schizotypy research: an introduction to the special supplement.

Authors:  Martin Debbané; Christine Mohr
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

Review 4.  Schizotypy: looking back and moving forward.

Authors:  Thomas R Kwapil; Neus Barrantes-Vidal
Journal:  Schizophr Bull       Date:  2014-12-29       Impact factor: 9.306

5.  The God Allusion : Individual Variation in Agency Detection, Mentalizing and Schizotypy and Their Association with Religious Beliefs and Behaviors.

Authors:  Rafael Wlodarski; Eiluned Pearce
Journal:  Hum Nat       Date:  2016-06

Review 6.  Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms.

Authors:  Elizabeth Kuipers; Philippa Garety; David Fowler; Daniel Freeman; Graham Dunn; Paul Bebbington
Journal:  Schizophr Bull       Date:  2006-08-02       Impact factor: 9.306

7.  Avoidant personality disorder is a separable schizophrenia-spectrum personality disorder even when controlling for the presence of paranoid and schizotypal personality disorders The UCLA family study.

Authors:  D L Fogelson; K H Nuechterlein; R A Asarnow; D L Payne; K L Subotnik; K C Jacobson; M C Neale; K S Kendler
Journal:  Schizophr Res       Date:  2007-02-15       Impact factor: 4.939

8.  Personality and Psychopathology: a Theory-Based Revision of Eysenck's PEN Model.

Authors:  Dirk van Kampen
Journal:  Clin Pract Epidemiol Ment Health       Date:  2009-12-08

9.  Nightmares in Patients With Psychosis: The Relation With Sleep, Psychotic, Affective, and Cognitive Symptoms.

Authors:  Bryony Sheaves; Juliana Onwumere; Nadine Keen; Daniel Stahl; Elizabeth Kuipers
Journal:  Can J Psychiatry       Date:  2015-08       Impact factor: 4.356

10.  The Psychosis Continuum: Testing a Bifactor Model of Psychosis in a General Population Sample.

Authors:  Mark Shevlin; Eoin McElroy; Richard P Bentall; Ulrich Reininghaus; Jamie Murphy
Journal:  Schizophr Bull       Date:  2016-05-24       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.